Related Experiment Video

Updated: Aug 8, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies

S Zaja-Milatovic1, C D Keene, K S Montine

  • 1University of Washington, Seattle, WA 98104, USA.

Neurology
|May 24, 2006
PubMed

Insights

Dementia with Lewy bodies (DLB) causes significant executive dysfunction. This study found selective neuron degeneration in the caudate nucleus, potentially explaining the severe executive deficits in DLB patients.

Area of Science:

  • Neuroscience
  • Neuropathology

Background:

  • Dementia with Lewy bodies (DLB) is the second most prevalent dementia.
  • DLB patients exhibit more pronounced executive function deficits than Alzheimer disease patients.

Purpose of the Study:

  • To investigate the neuropathological basis of executive dysfunction in DLB.
  • To identify specific neuronal changes in the caudate nucleus associated with DLB.

Main Methods:

  • Histopathological examination of brain tissue.
  • Analysis of neuronal morphology in the caudate nucleus.

Main Results:

  • Demonstrated selective spinodendritic degeneration of medium spiny neurons.
  • Identified degeneration in caudate nucleus regions critical for executive functions.

Conclusions:

  • Spinodendritic degeneration of specific medium spiny neurons may underlie executive dysfunction in DLB.
  • Findings offer a potential neuropathological explanation for heightened executive deficits in DLB.

More Related Videos

Dendritic Spine Quantification Using an Automatic Three-Dimensional Neuron Reconstruction Software07:45

Dendritic Spine Quantification Using an Automatic Three-Dimensional Neuron Reconstruction Software

Published on: September 27, 2024

Technique for Intranasal Administration of α-Synuclein Aggregates04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...